Interleukin-12 in the treatment of chronic hepatitis B and C. (Q53883948)

22 May 2018

title

Interleukin-12 in the treatment of chronic hepatitis B and C. (English)

1 reference

22 May 2018

0 references

1 reference

1 reference

Zeuzem S

1

1 reference

22 May 2018

Carreño V

series ordinal

2

1 reference

22 May 2018

publication date

1 November 2001

1 reference

22 May 2018

published in

Antiviral Research

1 reference

22 May 2018

volume

52

1 reference

22 May 2018

issue

2

1 reference

22 May 2018

page(s)

181-188

1 reference

22 May 2018

Different cytokine profiles of intraphepatic T cells in chronic hepatitis B and hepatitis C virus infections.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900183-8

7 January 2021

Antitumor and antimetastatic activity of interleukin 12 against murine tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900183-8

7 January 2021

A phase I/II study of recombinant human interleukin-12 in patients with chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900183-8

7 January 2021

Hepatitis B virus immunopathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900183-8

7 January 2021

Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900183-8

7 January 2021

Impaired interferon induction of human MxA protein in chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900183-8

7 January 2021

Administration of recombinant IL-12 to normal mice enhances cytolytic lymphocyte activity and induces production of IFN-gamma in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900183-8

7 January 2021

Interleukin-12: potential clinical applications in the treatment and prevention of infectious diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900183-8

7 January 2021

Interleukin-12: potential clinical applications in the treatment of chronic viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900183-8

7 January 2021

In vivo treatment with interleukin 12 protects mice from immune abnormalities observed during murine acquired immunodeficiency syndrome (MAIDS).

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900183-8

7 January 2021

Interleukin-12 profoundly up-regulates the synthesis of antigen-specific complement-fixing IgG2a, IgG2b and IgG3 antibody subclasses in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900183-8

7 January 2021

Interleukin 12 suppresses autoantibody production by reversing helper T-cell phenotype in hepatitis B e antigen transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900183-8

7 January 2021

Mechanism of interleukin 12-mediated toxicities during experimental viral infections: role of tumor necrosis factor and glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900183-8

7 January 2021

Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900183-8

7 January 2021

The in vivo antiviral activity of interleukin-12 is mediated by gamma interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900183-8

7 January 2021

Induction of interleukin-12 production in chronic hepatitis C virus infection correlates with the hepatocellular damage

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900183-8

7 January 2021

Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900183-8

7 January 2021

Interleukin-12 induction of Th1 cytokines is important for viral clearance in chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900183-8

7 January 2021

IL-12: initiation cytokine for cell-mediated immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900183-8

7 January 2021

Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900183-8

7 January 2021

A phase I/II study of recombinant human interleukin-12 in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900183-8

7 January 2021

10.1016/S0166-3542(01)00183-8

Identifiers

DOI

1 reference

22 May 2018

PubMed ID

11672828

1 reference

22 May 2018